Stereotactic Laser Ablation for Temporal Epilepsy
A study for patients with temporal epilepsy using laser ablation
Sponsor: Medtronic Navigation, Inc
Enrolling: Male and Female Patients
IRB Number: AAAR0094
U.S. Govt. ID: NCT02844465
Contact: Guy McKhann: 212-305-0052 / gm317@cumc.columbia.edu
Additional Study Information: This research study plans to learn more about a device called the Visualase Thermal Therapy System (Visualase system). This device uses a thin laser probe that is inserted into the brain. The laser is turned on, heats up and destroys surrounding soft tissue. Before the surgeon turns on the laser, you will be in a magnetic resonance imaging (MRI) scanner. This lets the surgeon see an image of your brain, the laser probe placement, and how much tissue is being heated up and destroyed while it is happening in real time. Medtronic and participating investigators including the study doctor at Columbia University Medical Center/NY Presbyterian Hospital want to find out if using Visualase is safe and effective for treatment of people with drug resistant mesial temporal lobe epilepsy (MTLE). Drug-resistant MTLE is a condition when antiepileptic drugs (AEDs) do not help control seizures.
This study is closed
Investigator
Guy McKhann, MD
Do You Qualify?
Are you at least 18 years of age? Yes No
Do you still have uncontrolled epileptic seizures, even though you have tried at least two antiepilleptic drugs? Yes No
Have you had at least 12 seizures in the last year? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Guy McKhann
gm317@cumc.columbia.edu
212-305-0052